Selective transport of neurotransmitters and modulators by distinct volume-regulated LRRC8 anion channels by Lutter, D. et al.
 
Repository of the Max Delbrück Center for Molecular Medicine (MDC) 
in the Helmholtz Association  
 
https://edoc.mdc-berlin.de/16332   
 
 
 
 
 
Selective transport of neurotransmitters and modulators by distinct 
volume-regulated LRRC8 anion channels 
 
Lutter, D., Ullrich, F., Lueck, J.C., Kempa, S., Jentsch, T.J.  
 
 
 
 
This is a copy of the final article, which is published here by permission of the publisher and which 
appeared first in: 
 
Journal of Cell Science 
2017 MAR 15 ; 130(6): 1122-1133 
2017 FEB 12 (First published online: final version) 
doi: 10.1242/jcs.196253 
 
Publisher: The Company of Biologists Ltd. 
 
Copyright © 2017 The Authors. Published by The Company of Biologists Ltd. 
RESEARCH ARTICLE
Selective transport of neurotransmitters andmodulators by distinct
volume-regulated LRRC8 anion channels
Darius Lutter1,2,3, Florian Ullrich1,2, Jennifer C. Lueck1,2,3, Stefan Kempa2 and Thomas J. Jentsch1,2,4,*
ABSTRACT
In response to swelling, mammalian cells release chloride and
organic osmolytes through volume-regulated anion channels
(VRACs). VRACs are heteromers of LRRC8A and other LRRC8
isoforms (LRRC8B to LRRC8E), which are co-expressed in HEK293
and most other cells. The spectrum of VRAC substrates and its
dependence on particular LRRC8 isoforms remains largely unknown.
We show that, besides the osmolytes taurine and myo-inositol,
LRRC8 channels transport the neurotransmitters glutamate,
aspartate and γ-aminobutyric acid (GABA) and the co-activator
D-serine. HEK293 cells engineered to express defined subsets of
LRRC8 isoforms were used to elucidate the subunit-dependence
of transport. Whereas LRRC8D was crucial for the translocation of
overall neutral compounds like myo-inositol, taurine and GABA, and
sustained the transport of positively charged lysine, flux of negatively
charged aspartate was equally well supported by LRRC8E.
Disruption of LRRC8B or LRRC8C failed to decrease the transport
rates of all investigated substrates, but their inclusion into LRRC8
heteromers influenced the substrate preference of VRAC. This
suggested that individual VRACs can contain three or more
different LRRC8 subunits, a conclusion confirmed by sequential co-
immunoprecipitations. Our work suggests a composition-dependent
role of VRACs in extracellular signal transduction.
KEY WORDS: VSOAC, VSOR, Swelling-activated chloride channel,
ICl,vol, ICl,swell, Gliotransmission
INTRODUCTION
Neurons and astrocytes can release neurotransmitters and other
signaling molecules not only by vesicular exocytosis, but also
through channel-like mechanisms (Hamilton and Attwell, 2010;
Harada et al., 2015; Kimelberg et al., 1990; Pasantes-Morales et al.,
1994; Verkhratsky et al., 2016, 2012). Several channels have been
implicated in channel-like neurotransmitter release, including
connexin hemichannels and pannexins (Montero and Orellana,
2015; Orellana and Stehberg, 2014), P2X7 receptors (Duan et al.,
2003), bestrophins (Lee et al., 2010), and the volume-regulated
anion channel (VRAC) (Kimelberg et al., 1990; Pasantes-Morales
et al., 1994).
VRAC [also known as VSOR, volume-stimulated outward
rectifier (Okada, 1997)] is a major player in mammalian cell
volume regulation (Jentsch, 2016; Nilius et al., 1997; Pedersen
et al., 2016). This plasma membrane channel, which appears to be
expressed in all cells, is normally closed but can be activated by cell
swelling or other cellular signaling cascades. In most cells, VRAC
opening leads to an efflux of Cl−, which, together with an efflux of
K+ through independent K+ channels, lowers the intracellular
osmolarity and, by secondarily driving water efflux, results in
regulatory volume decrease. Cell swelling also stimulates an efflux
of organic ‘osmolytes’ such as myo-inositol, taurine and glutamate.
It was controversial whether this release occurs through VRAC or
through a distinct channel named VSOAC (for volume-sensitive
organic osmolyte/anion channel) (Jackson and Strange, 1993;
Shennan, 2008), but this issue has been resolved recently when
LRRC8 proteins were finally identified as constituents of VRAC
channels (Qiu et al., 2014; Voss et al., 2014).
VRACs are composed of LRRC8 heteromers of the obligatory
subunit LRRC8A (Qiu et al., 2014; Voss et al., 2014) and at least
one other LRRC8 isoform (LRRC8B, LRRC8C, LRRC8D or
LRRC8E) (Voss et al., 2014). Genomic disruption (Voss et al.,
2014) or siRNA-mediated knockdown (Qiu et al., 2014) of
LRRC8A not only abolishes the swelling-activated Cl− current,
ICl,vol, but also the efflux of taurine. Cellular taurine release is also
abolished in cells lacking all LRRC8 subunits except LRRC8A
[denoted LRRC8(B,C,D,E)−/−] (Voss et al., 2014). Hence, both
VRAC and the taurine-conducting ‘VSOAC’ are composed of
LRRC8 heteromers. Furthermore, hypotonicity-induced aspartate
efflux (thought to reflect glutamate efflux) is diminished when
LRRC8A expression is reduced by siRNA transfection (Hyzinski-
García et al., 2014).
In addition to being an important osmolyte, the sulfo-amino acid
taurine activates inhibitory glycine and, possibly, γ-aminobutyric acid
(GABA) receptors (Le-Corronc et al., 2011; Schmieden et al., 1989). It
might also serve as a gliotransmitter in central osmoregulation (Choe
et al., 2012; Hussy et al., 2000, 1997; Le-Corronc et al., 2011).
Glutamate [and to a lesser degree aspartate (Chen et al., 2005; Patneau
and Mayer, 1990)] activates excitatory glutamate receptors, with
swelling-induced release of glutamate thought to play a role in
pathological conditions such as stroke and spreadingdepression (Akita
and Okada, 2014). D-serine, a co-activator of ionotropic glutamate
receptors (Mothet et al., 2000), has also been suggested as potential
VRAC substrate (Martineau et al., 2014; Rosenberg et al., 2010),
whereas there is no clear evidence for VRAC-dependent transport of
the inhibitory neurotransmitter GABA (Franco et al., 2001).
Disruption of LRRC8 genes can now be used to stringently assess
whether these compounds are transported by VRACs.
The homology of LRRC8 proteins to pannexins and the size of
purified heteromers on native gels suggest that VRACs may be
hexameric complexes of LRRC8 proteins (Abascal and Zardoya,
2012; Syeda et al., 2016; Voss et al., 2014). Together with the
presence of five different LRRC8 genes, which are often co-
expressed in the same cell, a hexameric assembly suggests that thereReceived 1 August 2016; Accepted 31 January 2017
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could be a large number of differently composed VRAC channels
that may have different properties. Indeed, the LRRC8 subunit
composition determines the voltage-dependent inactivation of
VRAC currents at non-physiological, inside-positive potentials
(Ullrich et al., 2016; Voss et al., 2014), and their single-channel
amplitudes (Syeda et al., 2016). Furthermore, the LRRC8D subunit
is crucial for the VRAC-mediated cellular uptake of blasticidin S
(Lee et al., 2014) and of the anti-cancer drugs cisplatin and
carboplatin (Planells-Cases et al., 2015). It is also crucial for the
swelling-induced efflux of taurine (Planells-Cases et al., 2015).
However, the subunit-dependence of other organic VRAC
substrates remains unclear despite their potential importance in
extracellular signaling.
We now use HEK293 cell lines carrying genomic disruptions of
individual LRRC8 genes to rigorously test whether previously
postulated VRAC/VSOAC substrates are indeed transported by
LRRC8 heteromers and whether their transport depends on specific
LRRC8 subunits. While also studying the uncharged osmolyte
myo-inositol and positively charged lysine, we mainly focus on
neurotransmitters and modulators that were previously discussed as
VRAC substrates. Moreover, we show that GABA, the main
inhibitory neurotransmitter in the mammalian brain, permeates
through VRACs. The LRRC8 subunit-dependence of organic
substance transport suggests that disruption of specific LRRC8
isoforms may be useful to elucidate the importance of VRAC-
dependent neurotransmitter transport in health and disease.
RESULTS
VRACs transport several neurotransmitters and
neuromodulators
Wild-type (WT) and LRRC8A−/− HEK293 cells were loaded with
3[H]D-aspartate, 3[H]D-lysine, 3[H]D-serine, 3[H]GABA, 3[H]taurine
and 3[H]myo-inositol and subsequently exposed to hypo-osmotic
medium to open swelling-activated channels. We determined their
efflux bymeasuring the radioactivity of the supernatant, assuming that
these compounds have not been significantly metabolized during the
procedure. This assumption is reasonable for the D-amino acids,
taurine and myo-inositol. For 3[H]GABA efflux experiments we
inhibited GABA metabolism with the GABA transaminase inhibitor
vigabatrin. Although 3[H]D-aspartate has been widely used as non-
metabolizable analog of L-glutamate, we additionally assessed the
efflux of endogenous L-glutamate by determining its concentration in
the supernatant with an enzymatic assay.
The efflux of all tested substances was strongly increased by
hypotonic cell swelling (Fig. 1). The hypotonicity-induced flux
component was drastically reduced or abolished in LRRC8A−/−
cells, demonstrating that this component depends overwhelmingly
or exclusively on VRACs. As an exception, there may be a small
VRAC-independent component of swelling-induced myo-inositol
release (Figs 1G and 2). We conclude that besides the glycine-
receptor agonist taurine (Planells-Cases et al., 2015; Qiu et al.,
2014; Voss et al., 2014), LRRC8 channels can transport several
other neuroactive substances, including the major neurotransmitters
glutamate and GABA.
LRRC8D and LRRC8E are important for the transport of
organic molecules
We next asked which other LRRC8 subunits are required or,
together with LRRC8A, sufficient for the transport of these VRAC
substrates. The efflux of radiolabeled organic compounds was
studied with HEK293 cells lacking single LRRC8 subunits
(LRRC8A−/−, LRRC8B−/−, …, LRRC8E−/− cells) or carrying
disruptions in three LRRC8 genes, resulting in cells expressing
LRRC8A together with one other LRRC8 subunit [e.g.
LRRC8(B,C,E)−/− cells expressing only LRRC8A and LRRC8D].
For each substrate, maximal rates of hypotonicity-induced efflux
were normalized to those ofWT cells (Fig. 2; a complete timecourse
of efflux shown in Fig. S1).
Not only the obligate VRAC subunit LRRC8A, but also LRRC8D
played a crucial role in the transport of all tested organic compounds.
Swelling-induced taurine effluxwas almost absent from LRRC8D−/−
cells (Planells-Cases et al., 2015) (Fig. 2A). Lack of LRRC8D also
almost abolished VRAC-dependent transport of GABA and myo-
inositol, and markedly reduced the efflux of D-aspartate (Fig. 2A).
Conversely, LRRC8(B,C,E)−/− cells expressing only LRRC8A and
LRRC8D showed substantial transport of all tested compounds, with
taurine, GABA and myo-inositol efflux reaching or even exceeding
WT levels (Fig. 2B).
Disruption of LRRC8Emarkedly decreased the swelling-induced
efflux of D-aspartate, but not of GABA, taurine or myo-inositol
(Fig. 2A). Conversely, channels containing only LRRC8A and
LRRC8E subunits in a heteromeric complex of unknown and
possibly variable stoichiometry (denoted LRRC8A/E; hereafter,
the forward slash is used to denote the subunits present in the
heteromers) enabled a substantial efflux of D-aspartate, but not of
the other tested organic compounds (Fig. 2B).
By contrast, neither disruption of LRRC8B nor of LRRC8C
markedly reduced the efflux of any of the tested compounds
(Fig. 2A). Moreover, neither LRRC8A/B nor LRRC8A/C
heteromers conspicuously supported their transport (with
LRRC8A/C heteromers enabling aspartate and taurine transport to
a minor degree, Fig. 2B).
Given the important roles of LRRC8D and LRRC8E in the
transport of organic compounds, we next studied LRRC8(B,C)−/−
cells expressing LRRC8A together with both LRRC8D and
LRRC8E (Fig. 3A), or LRRC8(D,E)−/− cells lacking both
LRRC8D and LRRC8E (Fig. 3B). LRRC8(B,C)−/− cells displayed
up to a twofold higher swelling-induced efflux compared to
WT cells, suggesting that the genetic removal of LRRC8B and
LRRC8C increases the abundance of organic compound-
conducting LRRC8A/D, LRRC8A/E and probably LRRC8A/D/E
channels. Conversely, disruption of both LRRC8D and LRRC8E
almost abolished (myo-inositol) or strongly suppressed (D-aspartate
and taurine) transport of these compounds (Fig. 3B).
We conclude that LRRC8B and LRRC8C are neither required nor
sufficient (together with LRRC8A) for the transport of the tested
compounds, the exception being aspartate and taurine that can also
be transported, albeit less efficiently, by LRRC8A/C and, most
likely, LRRC8A/B/C heteromers.
In conclusion, LRRC8D has a major role in the permeability of
VRAC for all tested organic compounds and, when co-expressed
with LRRC8A, suffices for their efficient transport. However, as
already noticed previously for taurine (Planells-Cases et al., 2015),
LRRC8D is not absolutely required for VRAC-dependent transport
of organic substrates. LRRC8E stands out in transporting (together
with LRRC8A) aspartate apparently as efficiently as LRRC8D
(with minor effects on the other substrates), whereas LRRC8C also
supports the transport of aspartate and taurine but less efficiently.
Apparent substrate selectivity of cells expressing different
LRRC8 combinations
We next systematically determined the apparent selectivity of
HEK293 cells engineered to express, in addition to LRRC8A, only
one, two, or three other LRRC8 isoforms. Hypotonicity-induced
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Fig. 1. Swelling-induced efflux of neurotransmitters and modulators from HEK293 cells depends on LRRC8A. (A) Efflux of cellular glutamate was
measured by determining its levels in supernatant that was collected every 5 min. Cells were challenged with hypotonic solution at the time indicated by the arrow
and glutamate concentrations in supernatants were determined using an enzymatic detection assay (a.u., arbitrary units). (B–F) Efflux rate constants
of radiolabeled compounds from HEK293 cells that had been loaded with the indicated tracers. Radioactivity was measured in supernatants collected as in A.
Efflux rate constants were determined as described in the Materials and Methods. Throughout mean±s.e.m values are given, with n≥5 (n denoting the
number of wells tested). Note, error bars are often too small to be visible. Iso, efflux into isotonic (320 mOsm) medium; Hypo, efflux into hypotonic
medium (240 mOsm).
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efflux of D-aspartate, taurine and myo-inositol, as representing
negatively charged, zwitterionic and uncharged substrates,
respectively, was determined for each of these cell lines. To
compare fluxes quantitatively, we minimized variations in
experimental conditions by testing all three compounds on the
same batch of cells in a single experiment. We compared fluxes
within these single experiments by normalizing rate constants of
fluxes of taurine and myo-inositol to those of aspartate (Fig. 4). It
should be noted, however, that the measured transport ratios of
radioactively labeled compounds only serve to determine the
apparent selectivity of VRACs as a function of available LRRC8
subunits. These ratios do not reflect the relative total fluxes of
compounds since we ignore the intracellular concentration of the
corresponding unlabeled molecules. As discussed later, the ratios
neither reflect the selectivity of individual VRAC channels (i.e.
biophysical properties of defined LRRC8 heteromers) but rather the
physiologically important averaged selectivity of the entire ensemble
of differently composed heteromers expressed in these cells.
We compiled Fig. 4 to compare the effect of an ‘addition’ of a
particular LRRC8 isoform to a cell expressing sets of other
isoforms. For instance, we display in Fig. 4A,B the effect the
additional expression of LRRC8B has on taurine:aspartate andmyo-
inositol:aspartate flux ratios in cells expressing already two, three or
four LRRC8 isoforms in all possible combinations. The additional
expression of LRRC8B markedly increased the taurine:aspartate
transport ratios in cells expressing LRRC8D, the subunit that
enhances taurine flux (Fig. 2), but lacking LRRC8E (Fig. 4A).
However, the addition of LRRC8B had no consistent effect on the
myo-inositol:aspartate transport ratio (Fig. 4B). The increase of the
taurine:aspartate transport ratio upon addition of LRRC8B to cells
expressing LRRC8A and LRRC8D cannot be explained by the
expression of additional LRRC8A/B channels (which lack
significant transport activity, Fig. 2B), but rather suggests the
formation of VRACs that contain LRRC8A, LRRC8B and
LRRC8D subunits in a single heteromeric channel.
Conversely, addition of LRRC8C decreased the ratio of taurine
(Fig. 4C) or myo-inositol (Fig. 4D) to aspartate flux in cells
expressing only LRRC8A and LRRC8D (and simultaneously
lacking LRRC8E). This effect might be due to the formation of
separate LRRC8A/C channels that conduct taurine or myo-inositol
only poorly and compete with the formation of LRRC8A- and
LRRC8D-containing channels. However, a more likely scenario is
that insertion of LRRC8C into channels containing both LRRC8A
and LRRC8D decreases their taurine or myo-inositol over aspartate
transport ratio.
As expected from the crucial role of LRRC8D in taurine
(Planells-Cases et al., 2015) and, to a lesser extent, in aspartate
transport (Fig. 2), the ‘addition’ of LRRC8D increased the taurine:
aspartate transport ratio when added to all possible combinations of
LRRC8A with other isoforms (Fig. S2A). Conversely, the addition
of LRRC8E, which supports aspartate but not taurine transport
(Fig. 2), decreased the taurine:aspartate flux ratio of cells co-
expressing LRRC8D (i.e. the only cells displaying substantial
taurine transport) (Fig. S2C). Qualitatively similar effects of
LRRC8D or LRRC8E ‘addition’ were observed for the relative
flux ofmyo-inositol (Fig. S2B,D), which also depends on LRRC8D
but not LRRC8E (Fig. 2). In a proof-of-principle experiment, we
partially rescued the effect of LRRC8E disruption on apparent
channel selectivity by transient expression of LRRC8E (Fig. S2E,
F). Such rescue experiments are somewhat problematic as only a
fraction of cells are transfected, and because the overexpression in
those cells likely skews the channel assembly and may even lead to
an overall decrease in transport activity (Voss et al., 2014).
Sequential co-immunoprecipitation confirms that individual
VRACs can contain at least three different LRRC8 subunits
We sought to confirm the formation of VRACs containing more
than two different LRRC8 isoforms, which is suggested by our flux
measurements, by sequential co-immunoprecipitations. Different
epitopes were added to the C-termini of LRRC8A and LRRC8C and
these constructs were co-expressed, together with untagged
LRRC8E, in different combinations in LRRC8−/− HEK293 cells
(i.e. cells lacking all LRRC8 isoforms). In contrast to LRRC8B and
LRRC8D, these subunits can be robustly overexpressed in
transfected cells (Voss et al., 2014). Solubilized membrane
proteins were sequentially precipitated with beads coated with
nanobodies against epitopes fused to LRRC8A and LRRC8C and
the final precipitate probed with antibodies against LRRC8E
(Fig. 5). Negative controls included cells expressing untagged
LRRC8A and LRRC8C and the mixture of solubilized proteins
from cells expressing LRRC8A with either LRRC8C or LRRC8E.
These experiments established the presence of VRACs containing
all three LRRC8 subunits in the same complex (Fig. 5).
Fig. 2. Efflux of organic VRAC substrates as a function of LRRC8
isoforms. (A) Efflux of radiolabeled compounds in cells lacking one of the
subunits LRRC8A to LRRC8E, and (B) triple knockout cells in which only
LRRC8A together with either LRRC8B, LRRC8C, LRRC8D or LRRC8E are left
intact. Taurine efflux data shown for ‘D−/−’, ‘A+C’, ‘A+D’, and ‘A+E’ have been
published previously (Planells-Cases et al., 2015) and are depicted again for
comparison. Maximal swelling-induced rate constants were calculated and
normalized to respective WT values (indicated by dashed line). Values for
LRRC8A were partially derived from experiments shown in Fig. 1.
Mean±s.e.m. values of at least three (A) or two (B) independent experiments
(n=16 for A; and n=8 for B). *P≤0.05; **P≤0.01; ***P≤0.001 [Mann–Whitney
test compared with WT (A) or LRRC8A−/− (B) values].
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Electrophysiological characterization of different VRAC
heteromers
To compare fluxes of organic molecules to chloride currents, we
analyzed the swelling-activated VRAC current ICl,vol in all knockout
cell lines by using the patch clamp technique. While single LRRC8
gene disruptions affected inactivation kinetics as described for
HCT116 cells (Voss et al., 2014) (Fig. 6A), all single knockout
HEK293 cell lines (except LRRC8A−/− cells) still yielded robust
swelling-activated currents that did not differ significantly fromWT
in magnitude or rectification (Fig. 6C). Similarly, double knockouts
had only marginal effects on swelling-activated current densities
with the exception of LRRC8(C,E)−/− cells, which showed a
substantial reduction of currents (Fig. 6D). ICl,vol rectification
was increased in these cells, resembling currents reported for
LRRC8A/D heteromers (Syeda et al., 2016). We hypothesize that
currents in these cells are indeed mostly carried by LRRC8A/D
channels, since the LRRC8A/B combination was found to yield
only a very small ICl,vol in overexpression or reconstitution
Fig. 3. LRRC8D and LRRC8E as crucial subunits for swelling-induced transport of organic substrates. Swelling-induced efflux rate constants of 3[H]myo-
inositol, 3[H]D-aspartic acid and 3[H]taurine in HEK293 cells either expressing VRAC heteromers containing subunits A+D+E [LRRC8(B,C)−/− cells; A], or
subunits A+B+C [LRRC8(D,E)−/− cells; B] were determined as described in Fig. 2. n=4, error bars are s.e.m. Similar results were obtained in two independent
experiments. Cells were challenged with hypotonic solution at the time indicated by the arrow.
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experiments (Syeda et al., 2016; Voss et al., 2014). Accordingly,
no ICl,vol could be evoked in LRRC8(C,D,E)−/− cells, in which
only LRRC8A and LRRC8B are present (Fig. 6B,E). Cells only
expressing LRRC8A/C or LRRC8A/E heteromers yielded
substantial currents, which displayed the slow or fast inactivation
gating already reported for these combinations, respectively
(Fig. 6B,E; Voss et al., 2014). Reminiscent of our observations
in LRRC8(C,E)−/− cells, LRRC8A/D-expressing cells showed a
strongly reduced ICl,vol with more pronounced outward rectification
and intermediate inactivation gating (Fig. 6B,E).
We conclude that the ICl,vol in HEK293 cells is probably carried
by all LRRC8 isoforms. Whereas the LRRC8A/B combination was
not able to support chloride currents in LRRC8(C,D,E)−/− HEK293
cells (Fig. 6B), small ICl,vol currents were detected in HCT116 cells
with the same LRRC8 genotype (Voss et al., 2014), demonstrating
that LRRC8B is indeed able to form functional VRACs with
LRRC8A alone. LRRC8D, while pivotal for the transport of
organic compounds, was able to produce an ICl,vol in LRRC8A/D
heteromers, albeit with strongly reduced current amplitudes
(Planells-Cases et al., 2015) and changed inactivation kinetics
(Fig. 6B). On the other hand, LRRC8A/C and LRRC8A/E
supported WT-like ICl,vol, differing only in inactivation at strongly
depolarized membrane potentials.
To assess electrogenic transport of organic substrates through
VRACs, we measured swelling-activated currents after replacing a
large part (105 mM) of the extracellular NaCl with NMDG-Cl,
Na-aspartate, Na-glutamate, or taurine (the latter at pH 8.35 to
obtain mainly negatively charged ions) (Fig. S3A,B). Surprisingly,
we did not find significant differences in reversal potential
shifts between wild-type VRACs and LRRC8A/C, LRRC8A/D,
and LRRC8A/E heteromers for any of the tested compounds
(Fig. S3A,B). The shift in reversal potentials upon partial external
Cl− replacement (Fig. S3A,B) was significantly different from the
calculated shift in Cl− reversal potential, indicating a contribution of
currents carried by organic anions. To more sensitively test for such
currents and their dependence on VRAC, we completely replaced
external (but not internal) Cl− by these compounds and compared
currents at inside-positive voltages between HEK293 cells
displaying different LRRC8 genotypes (Fig. S3C,D). Whereas
outward currents carried by Cl− influx were clearly different
between the different genotypes (and almost absent in LRRC8−/−
cells, as expected), organic anion-mediated outward currents
(i.e. organic anion influx) were independent of LRRC8 proteins
as they displayed similar amplitudes in LRRC8−/− cells. This
suggests the presence of a VRAC-independent electrogenic uptake
of organic anions at strongly positive potentials. The VRAC-
(LRRC8-)dependent transport of organic compounds that we
have established by flux measurements cannot be detected
by electrophysiological methods in HEK293 cells because of
background problems.
Fig. 4. Apparent substrate selectivity of differently composed VRAC heteromers. Influence of additional expression of LRRC8B (A,B) or LRRC8C (C,D) on
the ratio of 3[H]taurine (A,C) or 3[H]myo-inositol (B,D) over 3[H]D-aspartate transport. Values shown represent rate constants for taurine (A,C) or myo-
inositol (B,D) (15 min after changing to hypotonic medium) normalized to rate constants for D-aspartate at the same time. Ratios of respective rate constants are
depicted as bars that are grouped to easily compare HEK293 clones lacking (dark bars) or expressing (light bars) LRRC8B or LRRC8C, respectively. The
dotted line in A and C reflects D-aspartate efflux rates but is cut off in B and D due to small values. Experiments used various knockout cell lines in which all
LRRC8 subunits are expressed from endogenous promotors. Mean±s.e.m. values of two independent experiments (n=4 each for each substrate) are shown.
*P≤0.05; **P≤0.01; ***P≤0.001 (Mann–Whitney test).
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DISCUSSION
Over the past decades many organic compounds have been
suggested to be transported by VRAC or other volume-regulated
osmolyte or anion channels, but the unknown identity of the
proteins forming VRACs precluded rigorous conclusions. We have
now demonstrated that several chemically distinct organic
compounds permeate LRRC8 (VRAC) channels and discovered a
special role of LRRC8D and LRRC8E subunits in the transport of
all tested organic compounds, and of electrically negatively charged
aspartate and glutamate, respectively. Our work reveals that several
neurotransmitters and co-activators pass through VRACs, including
the main inhibitory neurotransmitter GABA, which had not been
previously recognized as VRAC substrate. This suggests that
differently composed VRACs may play important modulatory roles
in the signal transduction in the nervous system.
VRACs as major osmotically-induced pathway for various
organic compounds
LRRC8A is the only obligatory VRAC subunit (Qiu et al., 2014;
Voss et al., 2014). It forms functional channels with any of the four
other LRRC8 isoforms and is needed for their transport to the
plasma membrane (Voss et al., 2014). Disruption of LRRC8A using
CRISPR/Cas9 genomic editing provides an easy and stringent test
for the involvement of VRAC in defined transport processes (Voss
et al., 2014). It gives more clear-cut results than siRNA knockdown
(Hyzinski-García et al., 2014; Qiu et al., 2014) and is by far superior
to pharmacological studies as there are no specific VRAC inhibitors.
Of note, several VRAC inhibitors also block pannexins, connexins
and glutamate transporters (Abdullaev et al., 2006; Benfenati et al.,
2009; Bowens et al., 2013; Ye et al., 2009), all of which are
candidate proteins for the release of amino acids.
Disruption of LRRC8A abolished the bulk of hypotonicity-
activated cellular efflux of L-glutamate, D-aspartate, D-lysine,
D-serine, GABA, taurine and myo-inositol (Fig. 1), identifying
VRACs as the major swelling-activated efflux pathway for these
compounds in HEK293 cells. Together with platinum-based drugs
(Planells-Cases et al., 2015) and blasticidin S (Lee et al., 2014), we
now have a large list of confirmed organic substrates of LRRC8
channels. The diverse physicochemical properties of organic VRAC
substrates suggest a rather wide and poorly specific permeation
pathway. A poorly selective pore that conducts structurally
dissimilar and differently charged organic compounds seems to
contrast with the ability of VRACs to strongly discriminate between
inorganic anions and cations and mildly even between iodide and
chloride ions (Gosling et al., 1995; Kubo and Okada, 1992; Nilius
et al., 1997; Pedersen et al., 2016). This apparent discrepancy may
now be partially explained by the presence of different LRRC8
heteromers with different pore properties.
VRAC versus VSOAC
For a long time, it has remained unclear whether ‘VRAC’, the
volume-regulated anion channel, is distinct from ‘VSOAC’
(Jackson et al., 1994), the volume-sensitive organic osmolyte/
anion channel (Shennan, 2008). Transport of both halides and
organic osmolytes (e.g. taurine) was stimulated by cell swelling and
could be inhibited by an overlapping spectrum of (non-specific)
inhibitors. However, halide and organic osmolyte efflux increased
with different timecourses after exposure to hypotonicity and their
sensitivity to drugs differed in detail, leading to the proposal that
‘VRAC’ is different from ‘VSOAC’ (Lambert and Hoffmann, 1994;
Shennan, 2008; Stutzin et al., 1999). This hypothesis was further
supported by the conceptual difficulty of imagining channel pores
transporting comparatively large organic compounds while
displaying pronounced anion selectivity with small inorganic ions.
The discovery that LRRC8A is indispensable for both swelling-
activated Cl− currents and taurine fluxes (Qiu et al., 2014; Voss
et al., 2014) was compatible with VRAC being identical to VSOAC.
However, cells may express different LRRC8 heteromers that differ
in inactivation kinetics (Voss et al., 2014) and substrate selectivity
(Planells-Cases et al., 2015; Syeda et al., 2016). Taurine transport
Fig. 5. Sequential co-immunoprecipitation of VRAC heteromers. Sequential co-immunoprecipitation (IP) of LRRC8 heteromers with antibodies against
LRRC8A and LRRC8C, respectively, and probing for LRRC8E reveals the presence of heteromers containing all three subunits. HEK293 LRRC8−/− cells lacking
all five LRRC8 isoforms were transfected with Myc-tagged LRRC8A (LRRC8Amyc), GFP-tagged LRRC8C (LRRC8CGFP) and untagged LRRC8E. Solubilized
proteins were sequentially affinity-purified with anti-Myc and anti-GFP antibodies. Controls include untagged LRRC8A or LRRC8C (fractions 2 and 3,
respectively). In the ‘mix control’, HEK293 LRRC8−/− cells were transfected either with LRRC8Amyc and LRRC8CGFP, or LRRC8Amyc and LRRC8E, respectively,
and cell lysates pooled prior to the first affinity purification to control for in vitro aggregation of A/C and A/E VRAC heteromers.
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through VRAC depends very strongly, though not absolutely
(Fig. 3B ; Planells-Cases et al., 2015), on the presence of LRRC8D,
as does the transport of blasticidin S (Lee et al., 2014) and of the
anti-cancer drugs cisplatin and carboplatin (Planells-Cases et al.,
2015). We now showed that LRRC8D also has a pivotal role for the
transport of aspartate, lysine, GABA and myo-inositol (Fig. 2A,B).
However, LRRC8D is not the only VRAC subunit supporting the
transport of organic compounds. This is particularly evident for
aspartate, which was transported by LRRC8A/D- or LRRC8A/E-
expressing cells with similar efficacies, and which could also pass
through LRRC8A/C (Fig. 2B) and LRRC8A/B/C (Fig. 3B) channels.
Hence organic compound-transporting ‘VSOACs’ cannot be
discriminated from halide ion-transporting ‘VRACs’ by the presence
of LRRC8D or LRRC8E. Of note, LRRC8A/E, LRRC8A/C and (to a
lesser degree) LRRC8A/D heteromers also yield Cl− currents (Fig. 6).
While this suggests that there is no separation into exclusively
halide- or organic compound-selective pores, we cannot exclude
the possibility that, for instance, LRRC8AandLRRC8Dcan assemble
to hexamers with different stoichiometries, resulting in two classes
of channels that transport exclusively either halides or organic
compounds. Although LRRC8D-containing VRACs are more
‘VSOAC-like’, a strict conceptual separation into VRAC and
VSOAC channels does not seem warranted.
LRRC8D and LRRC8E in the transport of neutral and
negatively charged organic compounds
Whereas LRRC8D, together with LRRC8A, supported the transport
of all tested organic compounds, LRRC8E rather specifically
supported the transport of the negatively charged aspartate. Since
swelling-induced Cl− currents were also larger with LRRC8A/E
Fig. 6. Electrophysiological
characterization of VRAC currents in
HEK293 cells expressing different
LRRC8 combinations.
(A,B) Representative VRAC current
(ICl,vol) traces in response to the voltage
clamp protocol shown in (A) applied to
cells in which one (A) or three (B)
LRRC8 isoforms were genetically
disrupted. Dashed lines indicate zero
current. (C,D,E) ICl,vol current densities
at +100 mV (top) or –100 mV (middle),
and the rectification coefficient
(bottom) of the indicated LRRC8
single- (C), double- (D), or triple-
knockout cell lines (E). Error bars are
s.e.m. All experiments were repeated in
8–12 independent cells on at least
three different days.
1129
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 1122-1133 doi:10.1242/jcs.196253
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
than with LRRC8A/D channels (Fig. 6), we hypothesize that
LRRC8E enhances the transport of negatively charged ions. In
contrast, LRRC8D allows the transport of organic compounds
irrespective of charge, that is, negatively charged aspartate,
electrically neutral molecules [either uncharged like myo-inositol
or zwitterionic (such as taurine, serine, and GABA at physiological
pH)], partially positively charged compounds such as cisplatin
(Planells-Cases et al., 2015) and blasticidin S (Lee et al., 2014), and
even almost fully positively charged lysine.
Disruption of LRRC8B or LRRC8C did not decrease the
transport of organic compounds (Fig. 2A). LRRC8(C,D,E)−/−
HEK293 cells expressing only LRRC8A/B virtually lacked both
transport of organic compounds and ICl,vol (Figs 2B and 6).
However, LRRC8(C,D,E)−/− HCT116 cells do yield VRAC
currents (Voss et al., 2014), suggesting that HEK293 cells might
express very few LRRC8A/B channels, precluding conclusions on
their ability to transport organic substrates. LRRC8A/C channels,
on the other hand, were clearly able to support aspartate flux, but
mediated only small or insignificant transport of taurine (Planells-
Cases et al., 2015), GABA and myo-inositol (Fig. 2B).
Complexity of LRRC8 heteromers
Based on the homology of LRRC8 proteins to pannexins (Abascal
and Zardoya, 2012), VRACs are believed to assemble into hexamers
(Syeda et al., 2016; Voss et al., 2014). The obligatory subunit
LRRC8A can bind to any of the other LRRC8 proteins as
demonstrated by functional assays (Planells-Cases et al., 2015;
Voss et al., 2014) and co-immunoprecipitation (Lee et al., 2014;
Syeda et al., 2016; Voss et al., 2014). As most WT cells probably
express four to five LRRC8 genes, albeit to different degrees (Voss
et al., 2014), individual cells may express a large variety of different
VRAC channels. These contain at least two and possibly up to five
different LRRC8 subunits within an individual channel. Our
experiments therefore reflect average transport properties of an
ensemble of different channels. This may even be true when cells
express only two different LRRC8 proteins, because they might
assemble with different stoichiometries. So far, we have no clue on
these stoichiometries.
Our functional assays (Fig. 4A) and sequential co-
immunoprecipitations (Fig. 5) now revealed that individual
VRACs may contain more than two LRRC8 subunits. Under the
assumption that all subunits can assemble with identical affinities
and that VRACs are hexamers, cells expressing three or more
different LRRC8 subunits to about the same level will contain only
minute amounts of VRACs composed of only two different LRRC8
isoforms. Although we cannot assign the transport activities
assessed here to single, defined heteromeric channels, our work
has revealed the contributions of particular LRRC8 isoforms to the
transport of different substrates.
We also tried to electrophysiologically characterize the transport
of organic compounds by diverse LRRC8 heteromers by measuring
reversal potentials with aspartate, glutamate or taurine as charge
carriers. Whereas native VRACs have been suggested to yield
currents with organic anions (Banderali and Roy, 1992; Boese et al.,
1996; Jackson and Strange, 1993; Manolopoulos et al., 1997), this
notion could not be rigorously tested previously owing to the lack of
genetic and specific pharmacological tools. We now showed that, at
least in HEK293 cells, organic anion-mediated currents at positive
voltages are almost totally independent of VRAC. Hence, previous
reports on organic anion-mediated currents through VRAC should
be viewed with caution. Indeed, a pioneering study by Banderali
and Roy (1992) used Ca2+- and ATP-free intracellular solutions,
which preclude the activation of VRACs (Jackson et al., 1994;
Nilius et al., 1997). The LRRC8-independent organic anion current
identified here was only observed at non-physiological, positive
voltages. Hence, it does not interfere with the VRAC-dependent
transport of neurotransmitters and other compounds, which we
studied using radiotracer fluxes at physiological potentials.
A recent report on LRRC8 channels heterologously expressed in
Xenopus oocytes (Gaitán-Peñas et al., 2016) did not reveal
significant differences in reversal potentials for several organic
compounds (including glutamate, aspartate and lactate) between
different LRRC8 heteromers, with the exception of taurine and
glycine that seemed to better permeate LRRC8A/D than
LRRC8A/C or LRRC8A/E channels. The reason for the apparent
discrepancy to our work is unclear, but might be related to
differences in background currents between Xenopus oocytes and
HEK293 cells. Unlike our LRRC8−/− HEK293 cells, oocytes
endogenously express LRRC8 proteins, which might heteromerize
with heterologously expressed subunits and confound results. The
same report (Gaitán-Peñas et al., 2016) failed to detect differences
between differently composed LRRC8 channels in fluxing organic
compounds due to a saturation of uptake in their experiments
(Gaitán-Peñas et al., 2016), in stark contrast to our work which
revealed highly relevant differences between diverse VRACs to
transport organic compounds.
VRACs in the release of neurotransmitters
Our experiments showed that LRRC8 heteromers (VRACs) can
transport several neurotransmitters and modulators, including the
main excitatory and inhibitory neurotransmitters glutamate and
GABA, respectively, as well as the co-activator D-serine and the
glycine receptor agonist taurine. In the brain, the role of VRAC in
releasing neurotransmitters and modulators may be similarly
important to its function in cell volume regulation, or even more
so. Both neurons and astrocytes express VRACs (Akita and Okada,
2014), and contain the neurotransmitters and co-agonists studied
here. Astrocytes take up extracellular glutamate and GABA through
ion-coupled transporters to remove them from the extracellular
space after their exocytosis at synapses. Moreover, astrocytes
not only synthesize glutamate, but also GABA (Yoon et al.,
2014) and D-serine (Wolosker et al., 1999). VRAC-mediated
neurotransmitter release may be more prominent with astrocytes
than with neurons because they are more prone to swell, at least
under hypoxic conditions (Mongin, 2015). On the other hand,
axons swell slightly upon action potential firing (Fields andNi, 2010;
Iwasa et al., 1980; Kim et al., 2007) and may release ATP through
swelling-activated anion channels (Fields and Ni, 2010). A role
of VRACs in neurotransmitter release from neurons, however,
remains speculative.
By contrast, it is well established that astrocytes are capable of
releasing transmitters like glutamate, aspartate, D-serine, taurine
and ATP (Harada et al., 2015; Kimelberg et al., 1990; Parpura et al.,
1994; Pasantes-Morales et al., 1994). It has been suggested that
this ‘gliotransmitter’ release influences neuronal excitability,
adding a novel component to neuronal information processing
(Verkhratsky et al., 2016, 2012). The mechanisms by which
astrocytes release neurotransmitters include vesicle exocytosis,
reversal of transporters that normally remove neurotransmitters from
the extracellular space and channel-like processes (Hamilton and
Attwell, 2010; Montero and Orellana, 2015). Whereas VRAC/
VSOAC has been implicated in the swelling-activated release of
taurine, glutamate, aspartate and D-serine (Rosenberg et al., 2010),
its ability to release ATP is debated (Burow et al., 2015; Hazama
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et al., 1999; Hisadome et al., 2002) and might occur only at extreme
levels of hypotonic swelling (Gaitán-Peñas et al., 2016). Another,
molecularly unidentified maxi-anion channel may rather mediate
swelling-induced ATP release (Sabirov et al., 2016).
Two potential roles of VRACs in brain physiology and pathology
have received particular attention. VRACs may play a role in
systemic volume regulation by releasing taurine from swollen
astrocytes in the supraoptical nucleus. Taurine then activates
inhibitory glycine receptors on somata of adjacent osmosensing
neurons, which are themselves excited by hypertonic shrinkage and
secrete water-retaining vasopressin in the pituitary (Hussy et al.,
2000; Jentsch, 2016; Prager-Khoutorsky and Bourque, 2015;
Prager-Khoutorsky et al., 2014). In stroke, hypoxic swelling of
astrocytes may open VRACs that release glutamate, which in turn
activates neuronal glutamate receptors (Akita and Okada, 2014;
Inoue and Okada, 2007; Jentsch, 2016) and thereby increases infarct
size through ‘excitotoxicity’ (Inoue et al., 2007; Mongin, 2015;
Zhang et al., 2008). Interestingly, the brain almost lacks expression
of LRRC8E (Voss et al., 2014), a subunit shown here to enhance
aspartate (glutamate) efflux. Although LRRC8D-containing
VRACs also transport glutamate, the low brain expression of
LRRC8E may serve to minimize deleterious effects of this
excitatory neurotransmitter during volume regulation or other
processes that require VRAC opening. VRACs may also be
activated without an increase of cell volume by several signaling
molecules (Akita and Okada, 2011; Burow et al., 2015; Hyzinski-
García et al., 2014; Mongin and Kimelberg, 2002) and in the course
of apoptosis (Planells-Cases et al., 2015). If VRACs display low
basal transport activity (Planells-Cases et al., 2015), they might also
contribute to ambient (extracellular, extrasynaptic) GABA that has
been controversially attributed to a bestrophin-mediated release
from astrocytes (Diaz et al., 2011; Lee et al., 2010).
Hence, VRACs may be important players in modulating brain
function in physiology and pathology. The identification of individual
LRRC8 subunits in the transport of particular neuroactive molecules
now allows us to investigate these roles using subunit- and cell-
specific knockout mouse models. For instance, Lrrc8d−/− mice
will be useful to assess the biological role of VRAC-dependent
transport of taurine, inositol and GABA, while Lrrc8(b,c)−/− mice
may help to elucidate effects of overall increased transport of organic
compounds by VRAC. Moreover, the development of drugs
specifically inhibiting VRACs containing particular LRRC8 subunit
combinations, which seems possible (Planells-Cases et al., 2015),
may offer novel therapeutic opportunities by inhibiting the transport
of only a subset of VRAC substrates.
MATERIALS AND METHODS
If not stated otherwise, all experiments were performed at room temperature.
Measurement of swelling-induced efflux of endogenous
glutamate
Wild-type and LRRC8A−/− HEK293 cells were grown on poly-L-lysine-
coated (Sigma) six-well plates (Sarstedt) with Dulbecco’s modified Eagle’s
medium (DMEM), fetal calf serum (FCS) and penicillin-streptomycin (Pan
Biotech) to 70–80% confluency. Cell culture medium was aspirated and
wells werewashed 9× with 1 ml isotonic solution (in mM: 150 NaCl, 6 KCl,
1 MgCl2, 1.5 CaCl2, 10 glucose, 10 HEPES pH 7.4; 320±5 mOsm). The
final wash was collected and put on ice for later analysis. Cells were then
challenged with hypotonic solution (in mM: 105 NaCl, 6 KCl, 1 MgCl2, 1.5
CaCl2, 10 glucose, 10 HEPES pH 7.4, 240±5 mOsm) or isotonic solution as
control. Solution was exchanged every 5 min (30 min in total) with fresh
isotonic or hypotonic solution and supernatants were kept on ice. Samples
were then centrifuged at 27 g to remove cellular debris. 50 µl of the
supernatant were analyzed for glutamate content using the Amplex® Red
Glutamic Acid/Glutamate Oxidase Assay Kit (Life Technologies)
according to the manufacturer’s manual.
Efflux assays using radioactively labeled tracers
Efflux assays were performed as described previously (Planells-Cases et al.,
2015; Voss et al., 2014). HEK293 cells on poly-L-lysine-coated six-well
plates (∼70–80% confluent) were loaded with 2 µCi/ml 3[H]γ-aminobutyric
acid (Perkin Elmer), 3[H]D-aspartic acid, 3[H]D-serine, 3[H]myo-inositol,
3[H]D-lysine and 3[H]taurine (Hartmann Analytics) for 2 h (3[H]GABA,
60 min; 3[H]myo-inositol, overnight). HEK293 cells used for 3[H]GABA
efflux were preincubated for 24 h with 100 µM vigabatrin (Sigma-Aldrich)
to irreversibly inhibit intracellular GABA catabolism via GABA-
transaminase. We used HEK293 rather than HCT116 cells (Voss et al.,
2014) because they showed higher flux rates, which resulted in larger
hypotonic:isotonic flux ratios.
After washing, cells were incubated with isotonic solution for 20 min.
During this time, isotonic solution was exchanged every 5 min and kept for
later analysis. Cells were then challenged with hypotonic solution (control,
isotonic solution; both solutions as specified for glutamate efflux) for 30 min
(exchange of solution every 5 min, all fractions collected for analysis). Finally,
cells were lysed with 0.75 ml 0.1 M NaOH. Lysate was neutralized with
0.75 ml 0.1 M HCl. All fractions and lysates were analyzed for radioactivity
by scintillation counting with 10 ml of the scintillation cocktail Aquasafe 300
plus (Zinsser Analytics) in a Tri-Carb 2810 TR β-scintillation counter (Perkin
Elmer). Rate constants (min−1) were calculated as described previously (Qiu
et al., 2014). Rate constants of the final isotonic measurement were subtracted
from rate constants obtained under hypotonicity to obtain swelling-induced
rate constants. The maximal rate constants obtained were normalized to those
of WT cells within the same experiment.
Possibly owing to different cell densities or other slight variations in
experimental conditions, absolute flux rates for a given substrate and
LRRC8 combination varied between experiments. To compare flux rates of
different substrates for a particular LRRC8 combination, we therefore
measured fluxes of three different substrates with the same cell line in a
single experiment. This yielded well reproducible values for the flux ratios
for different substrates. Fig. 4 and Fig. S2 depict the ratio of taurine or myo-
inositol fluxes over those of D-aspartate, always measured at 15 min (when
the efflux rate constant is close to maximum). For the LRRC8E−/− rescue
experiment, cells were seeded on six-well plates and transiently transfected
with an LRRC8E–GFP construct using Fugene®HD transfection reagent
(Promega) 24 h prior to efflux measurements.
Generation of HEK293 cell lines with LRRC8 gene disruptions
using CRISPR/Cas9 technology
CRISPR/Cas9-mediated disruption of LRRC8 genes in HEK293 cells
was performed as described previously (Voss et al., 2014). In brief,
target single guide (sg)RNAs (see Table S2) were cloned into a pX330
vector and transfected into HEK293 cells together (at a 9:1 ratio) with a
plasmid used to express EGFP (pEGFP-C1). Two days after transfection,
individual fluorescent cells were FACS-sorted into 96-well plates
containing 80 µl preconditioned cell culture medium per well. Resulting
monoclonal cell lines were tested for sequence alterations by sequencing of
site-specific PCR amplicons. Only clones with frameshift mutations (except
for clone 3E7, which has a 21 nucleotide deletion in transmembrane domain
1, see Table S1) were chosen and gene disruption was confirmed by western
blotting (see Fig. S4) using antibodies described previously (Planells-Cases
et al., 2015). To disrupt multiple LRRC8 genes, respective sgRNAs (see
Tables S1,S2 for a list of target sequences) were transfected together, or cell
lines already carrying disrupted LRRC8 genes were used for a new round of
gene disruption.
Electrophysiology
The whole-cell patch clamp method was used to measure ICl,vol as described
previously (Planells-Cases et al., 2015; Voss et al., 2014). The pipette
solution contained (in mM): 40 CsCl, 100 Cs-methanesulfonate, 1 MgCl2,
1.9 CaCl2, 5 EGTA, 4 Na2ATP, and 10 HEPES, pH 7.2 with CsOH (290
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mOsm). The hypotonic saline used to elicit ICl,vol contained (in mM): 105
NaCl, 6 CsCl, 1 MgCl2, 1.5 CaCl2, 10 glucose, 10 HEPES, pH 7.4 with
NaOH (240 mOsm). To measure reversal potential shifts, NaCl in the
hypotonic saline was replaced with equimolar amounts of Na-aspartate or
Na-glutamate, or with 210 mM taurine (pH 8.35 with NaOH).
For recordings of currents mediated exclusively by organic anions, the
control solution contained (in mM): 114 NaCl, 6 HCl, 6 CsOH, 1 Mg-
gluconate2, 1.5 Ca(OH)2, 10 HEPES, pH 7.4 with NaOH (240 mOsm).
NaCl and HCl were replaced with equimolar amounts of Na-aspartate or Na-
glutamate, and aspartic acid or glutamic acid, respectively. The taurine
solution contained 228 mM taurine instead of NaCl and HCl (pH 8.35 with
NaOH, adjusted to 240 mOsm with mannitol).
Cells were held at −30 mV and a 2.6-s ramp protocol from −100 mV to
100 mV was applied every 15 s to monitor ICl,vol current densities
developing over time. Maximally activated ICl,vol was further
characterized by 2-s step protocols from −80 mV to 120 mV in 20 mV
increments, preceded and followed by 0.5-s steps to −80 mV to ensure full
recovery from inactivation. Reversal potentials were measured using 2-s
ramps from −80 mV to 80 mV preceded by 0.5-s steps to −80 mV.
Sequential co-immunoprecipitation
LRRC8−/− HEK293 cells lacking all five VRAC subunits were transiently
transfected (using polyethylenimine, Polysciences) with expression
constructs encoding Myc- or untagged LRRC8A, EGFP- or untagged
LRRC8C, and untagged LRRC8E (epitopes were fused to C-termini). At
24 h post transfection (from here on, all steps were performed at 4°C unless
stated otherwise), cells were collected and lysed in buffer containing 1% n-
dodecyl-β-maltoside (DDM, Glycon), 150 mM NaCl, 50 mM Tris-HCl
pH 7.5, 4 mM Pefabloc (Roth) and complete protease inhibitor cocktail
(Roche). In ‘mix controls’ (Fig. 5), lysates from differently transfected cells
were pooled. The lysate was cleared by centrifugation at ∼100,000 g for
45 min and incubated for at least 2 h with Myc-Trap®_MA beads
(Chromotek). After washing, proteins were eluted with Myc peptide
(Chromotek) and used for further precipitation using GFP-Trap® MA beads
(Chromotek). After three additional washes with 1 ml lysis buffer,
precipitates were eluted in 2× Laemmli sample buffer for 10 min at 75°C.
Finally, proteins were separated by SDS-PAGE and analyzed by western
blotting as indicated [using antibodies against LRRC8A and LRRC8E
described previously (Planells-Cases et al., 2015) and ch@GFP (Aves Labs)
for GFP detection]. Lysate equivalent to 25% and 1.6% of input for the first
and second immunoprecipitation, respectively, and eluate of the first
immunoprecipitation were loaded as reference.
Statistical analysis
Data are depicted as mean±s.e.m. (with n denoting the number of samples as
indicated in respective figure legends). To compare groups of values (as
shown in Figs 2 and 4 and Fig. S2), the Mann–Whitney test was employed,
where significance was considered as follows: *P≤0.05; **P≤0.01; and
***P≤0.001.
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Fig. S1: Efflux of organic VRAC substrates as function of LRRC8B-E subunits. Time 
course of swelling-induced efflux of radiolabeled organic compounds in HEK293 cells. 
(A-D) Efflux from cells in which single LRRC8 genes were disrupted (left panels), and from 
cells carrying disruptions in three LRRC8 genes, leaving only the obligatory LRRC8A and 
one other LRRC8 isoform (right panels) intact. Taurine efflux data shown for “LRRC8D-/-“, 
“A+C”, “A+D”, and “A+E” have been published previously (Planells-Cases et al., 2015) and 
are depicted again for comparison. Mean values of at least two independent experiments 
(n=4 per experiment), error bars=s.e.m. 
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Fig. S2: Effect of inclusion of LRRC8D or LRRC8E on apparent substrate selectivity of VRAC. Influence of 
additional expression of LRRC8D (A, B) or LRRC8E (C, D) on 3[H]-taurine (A, C) or 3[H]-myo-inositol (B, D) over 
3[H]-D-aspartate transport ratios. Ratios of respective maximal rate constants are depicted as bars which are grouped 
to easily compare HEK293 clones lacking (dark bars) or expressing (light bars) LRRC8D or LRRC8E, respectively. 
Experiments used various KO cell lines in which all LRRC8 subunits are expressed from endogenous promotors.  
(E, F) Effect of transiently transfected LRRC8E (light bars) on 3[H]-taurine (E) and 3[H]-myo-inositol (F) over 3[H]-D-
aspartate efflux ratio in LRRC8E-/- HEK293 cells. Mean values of two independent experiments (n=4 each for each 
substrate), error bars=s.e.m. *P ≤ 0.05; **P ≤ 0.01; and ***P ≤ 0.001 (Mann-Whitney test). 
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Fig. S3: Whole-cell patch recordings of amino acid currents in different HEK293 
LRRC8 knockout clones. (A) Relative shifts in reversal potential (ΔErev) of fully activated 
ICl,vol in different HEK293 LRRC8 knockout cell lines upon equimolar substitution of NaCl 
in the standard hypotonic bath solution (105 mM) with the indicated substances. All bath 
solutions additionally contained 11 mM Cl- (see Methods). The taurine bath solution 
contained 210 mM taurine at pH 8.35. Assuming a pKa value of 8.74 (The Merck Index, 
12th ed., Entry# 9241.), the concentration of anionic taurine was ~61 mM. Values from 
knockout cell lines were compared to WT values using one-way ANOVA and Bonferroni's 
test. Bars are mean ± s.e.m. n is indicated. Data are corrected for differing liquid junction 
potentials. (B) Averaged ICl,vol traces in response to 2-s-voltage ramps from -60 to 60 mV 
in the indicated cell lines with the indicated extracellular charge carriers. Dashed blue lines 
indicate reversal potentials. Liquid junction potentials were not corrected. The sweep width 
represents mean ± s.e.m. (C) Current densities at 80 mV (I/C) of swelling-activated 
currents from different HEK293 LRRC8 knockout cell lines with the indicated anionic 
charge carriers in the bath solutions. No additional Cl- was present (see Methods). The 
taurine solution contained ~66 mM anionic taurine assuming a pKa of 8.74.  Bars are mean 
± s.e.m. n is indicated. (D) Averaged current density traces in response to 2-s-voltage 
ramps from -80 to 80 mV in the indicated cell lines with the indicated extracellular charge 
carriers. The sweep width represents mean ± s.e.m. Liquid junction potentials were not 
corrected.  
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Fig. S4: LRRC8 subunit expression in different HEK293 LRRC8 knockout clones. 
Western blots showing the expression of LRRC8A through LRRC8E in single (A), double 
(B), triple (C) and quintuple (D) LRRC8 knockout clones. Specific bands are marked by 
black arrows. Tubulin or actin served as loading control. Note that absence of LRRC8A 
(A) leads to size shift of the other LRRC8 subunits, which cannot leave the ER without 
LRRC8A and are thus differently glycosylated. 
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Supplemental Table S1. Monoclonal HEK293 cell lines with LRRC8 gene disruption 
HEK293 cell line Clone name Construct used* Genetic modification Used for Figure 
LRRC8A-/- 3E7 3A a1: ∆21nt (T110-A130) 
a2: insertion of 1 nt (T after C123) 
1A/B/G, 2A/B 
1.13 3A homozygous insertion of 55 nt (after T121) 1C/E/F, 2A/B, 6C, S4A 
1.6 3A Homozygous net ∆13 nt (within A37-G138) 1D, 2A,B 
LRRC8B-/- B1 2B a1: ∆1nt (A449) 
a2: ∆25nt (G443-T467) 
a3: Insertion of 1 nt (T after C445) 
2A, 4A-D, 6A/C, S2A-D, S4A 
LRRC8C-/- C3 1C homozygous duplication of T119 2A, 4A-D, 6A/C, S2A-D, S4A 
LRRC8D-/- Dn3 1D a1: duplication of A325 
a2: ∆4nt (T321-C324) 
a3: ∆5nt (A325-C329) 
2A, 4A-D, 6A/C, S2A-D, S4A 
LRRC8E-/- E2 1E a1: deletion 1 nt (A94) 
a2: duplication of A94 
2A, 4A-D, 6A/C, S2A-F, S4A 
LRRC8(B,C)-/- (1)A10 2B, 1C B: a1: duplication of T446 
B: a2: ∆14 nt (C435-G448) 
3A, 4A-D, 6D, S2A-D, S4B 
C: homozygous duplication of T119 
LRRC8(B,D)-/- (2)E12 2B, 1D B: a1: ∆7nt (G444-G450) 
  a2: insertion of 1 nt (T after C445) 
4A-D, 6D, S2A-D, S4B 
D: a1: duplication of A325 
  a2: ∆4nt (T321-C324) 
  a3: ∆5nt (A325-C329) 
LRRC8(B,E)-/- (3)A3 2B, 1E B: a1: ∆1nt (A449) 
  a2: ∆25nt (G443-T467) 
  a3: Insertion of 1 nt (T after C445) 
4A-D, 6D, S2A-D, S4B 
E: homozygous ∆ 5 nt (T92-C96) 
LRRC8(C,D)-/- (4)E2 1C, 1D C: homozygous duplication of T119 4A-D, 6D, S2A-D, S4B 
D: a1: insertion of one nt (A after C324) 
  a2: ∆5nt (deletion G322-C328 and insertion of GG) 
LRRC8(C,E)-/- (5)A6 1C, 1E C: homozygous duplication of T119 4A-D, 6D, S2A-D, S4B 
E: homozygous duplication of A94 
LRRC8(D,E)-/- (6)E5 1D, 1E D: a1: duplication of A325 
  a2: ∆4nt (T321-C324) 
  a3: ∆5nt (A325-C329) 
3B, 4A/B, 6D, S2A-D, S4B 
E: homozygous duplication of A94 
LRRC8(C,D,E)-/- 3.6 1C, 1D, 1E C: homozygous duplication of T119 2B, 6B/E, S4C 
D: homozygous duplication of A325 
E: homozygous duplication of A95 
LRRC8(B,C,D)-/- 4.1 2B, 1C, 1D B: homozygous insertion of 2 nt (TT after A430) 2B, 4A-D, 6B/E, S2A/B, S3, S4C 
C: homozygous duplication of T119 
D: homozygous duplication of A325 
LRRC8(B,C,E)-/- 5.5 2B, 1C, 1E B: a1: duplication of T433 
  a2: ∆13nt (A433-C445) 
  a3: ∆5nt (C445-A449) 
2B, 4A-D, 6B/E, S2C/D, S3, S4C 
C: homozygous duplication of T119 
E: a1: duplication of A94 
    a2: ∆2nt (C95-C96) 
    a3: ∆8nt (A94-C101) 
LRRC8 (B,D,E)-/- 6.3 2B, 1D, 1E B: homozygous ∆2nt (T446-C447) 2B, 4A/B, 6B/E, S2A-D, S3, S4C 
D: homozygous duplication of A325 
E: a1: deletion 1 nt (A94) 
    a2: duplication of A94 
LRRC8(A,B,C,D,E)-/- 5xKO A4 3A, 2B, 1C, 1D, 1E A: a1: ∆14nt (C116-G129) 
  a2: ∆2nt (deletion G125-G129, insertion AAG) 
5, 6E, S3C/D, S4D 
B: homozygous insertion of 2 nt (TT after A430) 
C: homozygous duplication of T119 
D: homozygous duplication of A325 
E: a1:  duplication of A94 
    a2:  deletion 1 nt (A94) 
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Supplemental Table S2. SgRNA used for CRISPR/Cas9-guided LRRC8 gene 
disruption in HEK293 cells 
Target gene Construct Guide sequence (5´3´) Targeting strand Target location in protein 
LRRC8A            3A tgatgattgccgtcttcgggggg + aa 36-43 (in TMD1) 
LRRC8B            2B ggccacaaaatgctcgagcctgg - aa 147-154 (between TMD2 and TMD3) 
LRRC8C            1C atgctcatgatcggcgtgtttgg + aa35-42 (in TMD1) 
LRRC8D            1D gtggctctgagaggtatgtcagg - aa107-114 (between TMD1 and TMD2) 
LRRC8E            1E gctggccgagtacctcaccgtgg + aa26-34 (in TMD1) 
TMD = transmembrane domain. aa = amino acid. PAM sequence is underlined 
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